Skip to main content
SpringerLink
Log in
Book cover

Drug and Alcohol Abuse pp 192–209Cite as

Hallucinogens and Related Drugs

  • Chapter

  • 363 Accesses

Part of the book series: Critical Issues in Psychiatry ((CIPS))

Abstract

This chapter covers the variety of substances listed in Table 8.1, each of which can enhance sensory perceptions such as colors and sounds. However, the hallucinogens rarely produce schizophrenialike auditory hallucinations without insight in the context of a clear sensorium and, thus, are not truly “psychotomimetic.”1–4 In fact, when hallucinations do occur at high doses of these drugs, they are usually visual in nature, most often involving lights, colors, or geometric shapes, and the user is likely to understand (or have insight) into the relationship between the drug and the hallucinations.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Goodwin, D. W., & Guze, S. B. Psychiatric diagnosis (5th ed.). New York: Oxford University Press, 1996.

    Google Scholar 

  2. O’Brien, C. P. Drug addiction and drug abuse. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, et al. (Eds.), The pharmacological basis of therapeutics (9th ed.). New York: McGraw-Hill, 1995, pp. 557–577.

    Google Scholar 

  3. Crowley, T. J. Hallucinogen-related disorders. In H. I. Kaplan & B. J. Saddock (Eds.), Comprehensive textbook of psychiatry (6th ed.). Baltimore, MD: Williams & Wilkins, 1995, pp. 831–838.

    Google Scholar 

  4. Pechnick, R. N., & Ungerleider, J. T. Hallucinogens. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Lan-grod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 230–238.

    Google Scholar 

  5. Halpern, J. H. The use of hallucinogens in the treatment of addiction. In Addiction research (Vol. 4). Amsterdam: Harwood Academic Publishers, 1996, pp. 177–189.

    Google Scholar 

  6. Krebs-Thomson, R., Paulas, M. P., & Geyer, M. A. Effects of hallucinogens on locomotor and investigatory activity and patterns: Influence of 5-HT2A and 5-HT2C receptors. Neuropsychopharmacology 18:339–351, 1998.

    Article  PubMed  Google Scholar 

  7. Vollenweider, F. X., Vontobel, P., Hell, D., & Leenders, K. L. 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man—A PET study with [11C]raclopride. Neuropsychopharmacology 20:424–433, 1999.

    Article  PubMed  Google Scholar 

  8. Aghajanian, G. K., & Marek, G. J. Serotonin and hallucinogens, Neuropsychopharmacology 21(Suppl): 16S–23S, 1999.

    PubMed  Google Scholar 

  9. Kramer, H. K., Poblete, J. C., & Azmitia, E. C. Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: Evidence for a presynaptic localization involving the serotonin transporter (SERT). Neuropsychopharmacology 19:265–277, 1998.

    PubMed  Google Scholar 

  10. Morgan, M. J. Recreational use of “ecstasy” (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19:252–264, 1998.

    Article  PubMed  Google Scholar 

  11. Winger, G., Hofmann, F. G., & Woods, J. H. A handbook on drug and alcohol abuse (3rd ed.). New York: Oxford University Press, 1992, pp. 98–115.

    Google Scholar 

  12. Strassman, R. J., Quails, C. R., & Berg, L. M. Differential tolerance to biological and subjective effects of four closely spaced doses of N, N-dimethyltryptamine in humans. Biological Psychiatry 39:784–795, 1996.

    Article  PubMed  Google Scholar 

  13. Schuckit, M. A. Educating yourself about alcohol and drugs. New York: Plenum Publishing Co., 1998.

    Google Scholar 

  14. Grob, C. S., & Poland, R. E. MDMA. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 269–275.

    Google Scholar 

  15. Schuckit, M. A. MDMA (ecstasy): An old drug with new tricks. Vista Hill Foundation Newsletter, 23(2), 1994.

    Google Scholar 

  16. Schlemmer, R. F., Jr., Nawara, C., Heinze, W. J., et al. Influence of environmental context on tolerance to LSD-induced behavior in primates. Biological Psychiatry 21:314–317, 1986.

    Article  PubMed  Google Scholar 

  17. American Psychiatric Association. The diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Press, 1994.

    Google Scholar 

  18. Brown, J. K., & Malone, M. H. Some U.S. street drug identification programs. Journal of the American Pharmaceutical Association 13:670–674, 1973.

    PubMed  Google Scholar 

  19. Cohen, R. S. Adverse symptomatology and suicide associated with the use of methylenedioxy-methamphet-amine (MDMA; “Ecstasy”). Biological Psychiatry 39:819–820, 1996.

    Article  PubMed  Google Scholar 

  20. Curran, H. V., & Travill, R. A. Mood and cognitive effects of ±3,4-methylenedioxymetham phetamine (MDMA, ‘ecstasy’): Week-end ‘high’ followed by mid-week low. Addiction 92:821–831, 1997.

    PubMed  Google Scholar 

  21. Vollenweider, F. X., Gamma, A., Liechti, M., & Huber, T. Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naive healthy volunteers. Neuropsychopharmacology 19:241–251, 1998.

    PubMed  Google Scholar 

  22. Peroutka, S. J. (Ed.). Ecstasy: The clinical, pharmacological, and neurotoxicological effects of the drug MDMA. Boston: Kluwer Academic Publishers, 1990.

    Google Scholar 

  23. Steele, T. D., McCann, U. D., & Ricaurte, G. A. 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): Pharmacology and toxicology in animals and humans. Addiction 89:539–551, 1994.

    Article  PubMed  Google Scholar 

  24. Kalivas, P. W., Duffy, P., & White, S. R. MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology 18:469–479, 1998.

    Article  PubMed  Google Scholar 

  25. Green, A. R., Cross, A. J., & Goodwin, G. M. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”). Psychopharmacology 119:247–260, 1995.

    Article  PubMed  Google Scholar 

  26. Krystal, J. H., & Price, L. H. Chronic MDMA use: Effects on mood and neuropsychological function? American Journal of Drug and Alcohol Use 18:331–341, 1992.

    Article  Google Scholar 

  27. Steele, T. D., McCann, U. D., & Ricaurte, G. A. 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Pharmacology and toxicology in animals and humans. Addiction 59:539–551, 1994.

    Article  Google Scholar 

  28. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National Household Survey on drug abuse: Population estimates 1997. Rockville, MD: U.S. Department of Health and Human Services, 1998.

    Google Scholar 

  29. Johnston, L. D., O’Malley, P. M., & Bachman, J. G. National survey results on drug use from the Monitoring the Future Study, 1975–1997, Vol. I, Secondary School Students. Rockville, MD: National Institute on Drug Abuse, U.S. Department of Health and Human Services, 1998.

    Google Scholar 

  30. Cuomo, M. J., Dyment, P. G., & Gammino, V. M. Increasing use of “ecstasy” (MDMA) and other hallucinogens on a college campus. Journal of American College of Health 42:271–274, 1994.

    Article  Google Scholar 

  31. Schuster, P., Lieb, R., Lamertz, C., & Wittchen, H. U. Is the use of ecstasy and hallucinogens increasing? Results from a community study. European Addiction Research 4:75–82, 1998.

    Article  PubMed  Google Scholar 

  32. Editorial. Epidemiology of drug usage. Lancet 1:147-148, 1985.

    Google Scholar 

  33. Abruzzi, W. Drug-induced psychosis. International Journal of the Addictions 12:183–193, 1977.

    PubMed  Google Scholar 

  34. Bondi, M. W., Drake, A. I., & Grant, I. Verbal learning and memory in alcohol abusers and polysubstance abusers with concurrent alcohol abuse. Journal of the International Neuropsychological Society 4:319–328, 1998.

    PubMed  Google Scholar 

  35. Krystal, J. H., & Price, L. H. Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: Effects on mood and neuropsychological function. American Journal of Drug and Alcohol Abuse 18:331–341, 1992.

    Article  PubMed  Google Scholar 

  36. Kawasaki, A., & Purvin, V. Persistant palinopsia following ingestion of lysergic acid diethylamide (LSD). Archives of Ophthalmology 114:47–50, 1996.

    Article  PubMed  Google Scholar 

  37. Gouzoulis, E., Borchardt, D., & Hermle, L. A case of toxic psychosis induced by “Eve” (3,4-methylene-dioxymethamphetamine). Archives of General Psychiatry 50:75, 1993.

    Article  PubMed  Google Scholar 

  38. Hermle, L., Funfgeld, M., Oepen, G., et al. Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: Experimental psychosis as a tool for psychiatric research. Biological Psychiatry 32:976–991, 1992.

    Article  PubMed  Google Scholar 

  39. Goldstein, J. A. Niacin and acute psychedelic psychosis. Biological Psychiatry 19:272–273, 1984.

    PubMed  Google Scholar 

  40. Ungerleider, J. T., & Pechnick, R. N. Hallucinogens. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance abuse: A comprehensive textbook (3rd ed.). Baltimore, MD: Williams & Wilkins, 1996, pp. 230–238.

    Google Scholar 

  41. Lerner, A. G., Oyffe, I., Isaacs, G., & Signal, M. Protracted akathisia after risperidone withdrawal. American Journal of Psychiatry 154:437–438, 1997.

    PubMed  Google Scholar 

  42. Lerner, A. G., Finkel, B., Oyffe, I., et al. Clonidine treatment for hallucinogen persisting perception disorder. American Journal of Psychiatry 155:1460, 1998.

    PubMed  Google Scholar 

  43. McCann, U. D., & Ricaurte, G. A. MDMA “ecstasy” and panic disorder: Induction by a single dose. Biological Psychiatry 32:950–953, 1992.

    Article  PubMed  Google Scholar 

  44. Gouzoulis, E., Steiger, A., Ensslin, M., Kovar, A., & Hermle, L. Sleep EEG effects of 3,4-methylene-dioxymethamphetamine (MDE; “Eve”) in healthy volunteers. Biological Psychiatry 32:1108–1117, 1992.

    Article  PubMed  Google Scholar 

  45. Price, L. H., Ricuarte, G. A., Krystal, J. H., & Heninger, G. R. Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Archives of General Psychiatry 46:18–22, 1989.

    Google Scholar 

  46. Smith, C. G., & Asch, R. H. Drug abuse and reproduction. Fertility and Sterility 48:355–373, 1987.

    PubMed  Google Scholar 

  47. Abraham, H. D., & Aldridge, A. M. Adverse consequences of lysergic acid diethylamide. Addiction 88:1327–1334, 1993.

    Article  PubMed  Google Scholar 

  48. Redfearn, P. J., Agrawal, N., & Mair, L. H. An association between the regular use of 3,4-methylene-dioxymethamphetamine (Ecstasy) and excessive wear of the teeth. Addiction 93:745–748, 1998.

    Article  PubMed  Google Scholar 

  49. Kokotos Leonardi, E. T., & Azmitia, E. C. MDMA (Ecstasy) inhibition of MAO type A and type B: Comparisons with fenfluramine and fluoxetine (Prozac). Neuropsychopharmacology 10:231–238, 1994.

    Google Scholar 

  50. Bowen, J. S., Davis, G. B., Kearney, T. E., & Bardin, J. Diffuse vascular spasm associated with 4-bromo-2,5-dimethyoxyamphetamine ingestion. Journal of the American Medical Association 249:1477–1479, 1983.

    Article  PubMed  Google Scholar 

  51. Schuckit, M. A. The kitchen condiment high: Nutmeg. Vista Hill Foundation Newsletter, 26(6), 1997.

    Google Scholar 

  52. Fink, P. J., Goldman, M. J., & Lyons, I. Morning glory seed psychosis. Archives of General Psychiatry 15:209–213, 1966.

    Article  Google Scholar 

  53. Pfister, J. A., Stegelmeier, B. L., Cheney, C. D., et al. Operant analysis of chronic locoweed intoxication in sheep. Journal of Animal Science 74:2622–2632, 1996.

    PubMed  Google Scholar 

  54. Schuckit, M. A. Betel nut: A widespread drug of abuse. Vista Hill Foundation Drug Abuse & Alcoholism Newsletter, 21(1), 1992.

    Google Scholar 

  55. Talonu, N. T. Observations on betel nut use, habituation, addiction, and carcinogenesis. Papua New Guinea Medical Journal 32:195–197, 1989.

    PubMed  Google Scholar 

  56. Zacny, J. P., Cho, A. M., Toledano, A. Y., et al. Effects of information on the reinforcing, subjective, and psychomotor effects of nitrous oxide in healthy volunteers. Drug & Alcohol Dependence 48:85–95, 1997.

    Article  Google Scholar 

  57. Zacny, J. P., Klafta, J. M., Coalson, D. W., et al. The reinforcing effects of brief exposures to nitrous oxide in healthy volunteers. Drug and Alcohol Dependence 42:197–200, 1996.

    Article  PubMed  Google Scholar 

  58. Matthew, R. J., Wilson, W. H., Humphreys, D., & Lowe, J. V. Effect of nitrous oxide on cerebral blood velocity while reclining and standing. Biological Psychiatry 41:979–984, 1997.

    Article  Google Scholar 

  59. Haverkos, H. W., & Drotman, D. P. NIDA technical review: Nitrate inhalants. Biomedicine & Pharmacotherapy 50:228–230, 1996.

    Article  Google Scholar 

  60. Schuckit, M. A. The nitrite inhalants. Vista Hill Foundation Drug Abuse & Alcoholism Newsletter, 19(10), 1990.

    Google Scholar 

  61. Dax, E. M., Lange, W. R., & Jaffe, J. H. Allergic reactions to amyl nitrite inhalation. American Journal of Medicine 86:732, 1989.

    Article  PubMed  Google Scholar 

  62. Brandes, J. C., Bufill, J. A., & Pisciotta, A. V. Amyl nitrite-induced hemolytic anemia. American Journal of Medicine 86:252–254, 1989.

    Article  PubMed  Google Scholar 

  63. Mirvish, S. S., & Haverkos, H. W. Butyl nitrite in the induction of Kaposi’s sarcoma in AIDS. New England Journal of Medicine 317:1603, 1987.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of California Medical School and Veterans Affairs San Diego Healthcare System, San Diego, California, USA

    Marc A. Schuckit M. D. (Professor of Psychiatry)

Authors
  1. Marc A. Schuckit M. D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Schuckit, M.A. (2000). Hallucinogens and Related Drugs. In: Drug and Alcohol Abuse. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3232-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-3232-0_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-3234-4

  • Online ISBN: 978-1-4757-3232-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation